The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Adverse events (AEs) and the return of myelofibrosis (MF)-related symptoms after interruption or discontinuation of ruxolitinib (RUX) therapy.
Srdan Verstovsek
Research Funding - Incyte
Ruben A. Mesa
Research Funding - Incyte
Jason R. Gotlib
Consultant or Advisory Role - Incyte
Research Funding - Incyte
Vikas Gupta
Consultant or Advisory Role - Incyte; Novartis; Sanofi ; YM BioSciences
Honoraria - Incyte; Novartis
Other Remuneration - Incyte; Novartis
John F. DiPersio
No relevant relationships to disclose
John V. Catalano
Consultant or Advisory Role - Incyte; Novartis
Honoraria - Incyte; Novartis
Michael W.N. Deininger
Honoraria - Incyte
Carole Brennan Miller
Consultant or Advisory Role - Incyte; Novartis
Honoraria - Incyte; Novartis
Richard T. Silver
Consultant or Advisory Role - Incyte
Stock Ownership - Incyte
Honoraria - Incyte
Research Funding - Incyte
Moshe Talpaz
No relevant relationships to disclose
Elliott F. Winton
Consultant or Advisory Role - Incyte (U)
Honoraria - Incyte
Jimmie Huling Harvey
No relevant relationships to disclose
Murat O. Arcasoy
Research Funding - Incyte
Elizabeth O. Hexner
Research Funding - Incyte
Roger M. Lyons
Research Funding - Amgen; Celgene; Incyte; Novartis; Telik
Ronald Paquette
No relevant relationships to disclose
Azra Raza
No relevant relationships to disclose
William Sun
Employment or Leadership Position - Incyte
Stock Ownership - Incyte
Hagop Kantarjian
Research Funding - Incyte